26. Jahrestagung der Deutschen Retinologischen Gesellschaft
Deutsche Gesellschaft für Retinologie
27.09.2013, Hamburg
II. Genes and the retina – what matters?
Meeting Abstract
(13rg10)
[Volltext]
Next-generation sequencing: A new era in research and diagnostics of retinal dystrophies
Bolz HJ[Volltext]
Meeting Abstract
(13rg11)
[Volltext]
Retinal dystrophies – fundamental aspects of gene therapy
Leroy BP[Volltext]
Meeting Abstract
(13rg12)
[Volltext]
Methods in Genetics in inherited retinal disorders and Gene therapy trials
Zeitz C, Shamieh SE, Audo I, Sahel JA[Volltext]
Meeting Abstract
(13rg13)
[Volltext]
Evaluation of the effects of ranibizumab (Lucentis®) therapy on the macular function in patients with wet age-related macular degeneration using multifocal-electroretinogram and microperimetry
Reinsberg M, Hilgers RD, Lüke J, Nassar K, Grisanti S, Lüdeke I, Lüke M[Volltext]
Meeting Abstract
(13rg14)
[Volltext]
Standardized analysis of morphological OCT parameters and correlation with best-corrected visual acuity (BCVA) in antiangiogenic therapy of neovascular age-related macular degeneration (AMD)
Simader C, Waldstein S, Kundi M, Schmidt-Erfurth U[Volltext]
Meeting Abstract
(13rg15)
[Volltext]
Choroidal neovascularisation (CNV) during anti-VEGF therapy: Changes in microperimetric visual field defects are similar to changes in optical coherence tomography (OCT) findings in most cases
Inhoffen W, Hagemann U, Feucht M, Aisenbrey S, Bartz-Schmidt KU[Volltext]
Meeting Abstract
(13rg16)
[Volltext]
Identification of clinically relevant OCT parameters over two years of treatment in neovascular AMD
Schmidt-Erfurth U, Waldstein S, Kundi M, Simader C[Volltext]
Meeting Abstract
(13rg17)
[Volltext]
Treatment of wAMD patients with VEGF inhibitors: Insights from the routine clinical practice in Germany – the PONS Study
Agostini H, Mueller S, Ehlken C, Bauer-Steinhusen U, Hasanbasic Z, Wilke T[Volltext]
Meeting Abstract
(13rg18)
[Volltext]
The potential of the anti VEGF drugs cannot be used under real life conditions in Germany: Results from a 4 year follow up of 77 patients
Schrader WF, Bernhard A, Dietz C, Sommer K, Panidou E[Volltext]
Meeting Abstract
(13rg19)
[Volltext]
“Real-Life”-Data on Treatment of Diabetic Macular Oedema with Ranibizumab: Effect on Visual Acuity, OCT Development and the Number of Retinal Microaneurysms
Gerding H, Hefner L, Timmermann M[Volltext]
